Coronary artery revascularization after myocardial infarction

F Tarr1, G Lakos, I Tomcsányi

  • 1Postgraduate Medical School, Budapest, Hungary.

Acta Chirurgica Hungarica
|January 1, 1991
PubMed

Insights

This study on postinfarction patients with recurrent angina found improved functional status and perfusion despite reduced coronary artery patency after revascularization procedures. Further research is needed to optimize treatment strategies.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Recurrent angina pectoris post-myocardial infarction significantly impacts patient quality of life.
  • Revascularization strategies aim to improve myocardial perfusion and functional status in these patients.
  • Assessing the long-term efficacy of revascularization is crucial for guiding clinical practice.

Purpose of the Study:

  • To evaluate the revascularization effectiveness in postinfarction patients with recurrent angina.
  • To assess changes in myocardial perfusion and cardiac function 6-9 months after interventions.
  • To correlate procedural outcomes with improvements in New York Heart Association (NYHA) functional status.

Main Methods:

  • Noninvasive and invasive revascularization interventions were performed in 56 postinfarction patients.
  • Coronary angiography (recoronarography) was conducted in a subset of patients (n=12).
  • Functional status was assessed using NYHA classification, ejection fraction, and wall motion scoring via ventriculography and echocardiography. Dipyridamole Thallium scintigraphy was used to evaluate myocardial perfusion.

Main Results:

  • Recoronarography revealed a diminished patency rate, particularly in cases of presumed complete revascularization.
  • Ejection fraction and wall motion scores showed no significant improvement.
  • Dipyridamole Thallium scintigraphy demonstrated marked improvement in myocardial perfusion in all patients.
  • NYHA functional status significantly improved in the re-examined patient cohort.

Conclusions:

  • While coronary artery patency may decrease over time, revascularization interventions can lead to significant improvements in myocardial perfusion.
  • Enhanced perfusion correlates with improved functional capacity in postinfarction patients experiencing recurrent angina.
  • These findings suggest that functional status improvement is a key outcome measure, even with suboptimal angiographic patency.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...